{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:58Z","timestamp":1786119658480,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/gme.0b013e3181fa27e7","type":"journal-article","created":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T23:46:52Z","timestamp":1292888812000},"page":"515-520","source":"Crossref","is-referenced-by-count":1,"title":["Estimated risk of invasive breast cancer in postmenopausal women with and without family history of the disease"],"prefix":"10.1097","volume":"18","author":[{"given":"Angelina","family":"Sontag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Wickerham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth D.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Helt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Muram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-11-20210211","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","article-title":"Application of breast cancer risk prediction models in clinical practice.","volume":"21","author":"Domchek","year":"2003","journal-title":"J Clin Oncol"},{"key":"R4-11-20210211","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R5-11-20210211","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jnci\/86.8.600","article-title":"Validation of the Gail et al. model for predicting individual breast cancer risk.","volume":"86","author":"Spiegelman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R6-11-20210211","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence.","volume":"91","author":"Costantino","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R7-11-20210211","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","article-title":"Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.","volume":"91","author":"Gail","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R8-11-20210211","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R9-11-20210211","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/jnci\/djm223","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women.","volume":"99","author":"Gail","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R11-11-20210211","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3122\/jabfm.2009.03.080153","article-title":"Diffusion of breast cancer risk assessment in primary care.","volume":"22","author":"Guerra","year":"2009","journal-title":"J Am Board Fam Med"},{"key":"R12-11-20210211","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cdp.2007.08.003","article-title":"Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.","volume":"31","author":"Sabatino","year":"2007","journal-title":"Cancer Detect Prev"},{"key":"R13-11-20210211","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R14-11-20210211","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing Outcomes Relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R15-11-20210211","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"R16-11-20210211","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. erratum appears in JAMA 1999;282(22):2124.","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"R17-11-20210211","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1542\/peds.111.1.110","article-title":"Age at menarche and racial comparisons in US girls.","volume":"111","author":"Chumlea","year":"2003","journal-title":"Pediatrics"},{"key":"R18-11-20210211","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"R19-11-20210211","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0895-4356(03)00124-0","article-title":"Breast cancer risk prediction with a log-incidence model: evaluation of accuracy.","volume":"56","author":"Rockhill","year":"2003","journal-title":"J Clin Epidemiol"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/gme.0b013e3181fa27e7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:51:15Z","timestamp":1786042275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-201105000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181fa27e7","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}